Which hedge funds own LTRN? LANTERN PHARMA INC, Q2 2026 13F holders
4 of the hedge funds tracked by WhaleCreep disclosed a position in LTRN (LANTERN PHARMA INC) in their Q2 2026 13F filings, worth $1.6m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.0% of its book. 2 managers opened a new position this quarter: Citadel Advisors, Marshall Wace. 1 exited: Voss Capital.
4tracked managers holding
2opened this quarter
1exited this quarter
Which hedge funds hold LTRN? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.2m | 291,039 | 151% | added |
| Horizon Kinetics | Q2 2026 | 0.0% | $104.9k | 25,164 | -5% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $199.7k | 47,895 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $49.8k | 11,946 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Voss Capital | 0.2% | $68.5k |
How has hedge fund ownership of LTRN changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $1.6m |
| Q1 2026 | 3 | $263.6k |
| Q4 2025 | 3 | $569.6k |
| Q3 2025 | 3 | $778.2k |
| Q2 2025 | 3 | $531.5k |
| Q1 2025 | 3 | $593.3k |
| Q4 2024 | 3 | $529.8k |
| Q3 2024 | 2 | $409.5k |
| Q2 2024 | 2 | $516.5k |
| Q1 2024 | 2 | $831.4k |
| Q4 2023 | 2 | $310.2k |
| Q3 2023 | 2 | $232.3k |
| Q2 2023 | 2 | $422.2k |
| Q1 2023 | 2 | $263.9k |
| Q4 2022 | 1 | $127.0k |
| Q3 2022 | 1 | $102.0k |
Counts every tracked manager that disclosed LTRN in that quarter's filing, including managers that have since stopped filing.